Under depression conditions, the expression of GRs decreases, which weakens the inhibition of the HPA axis, leading to the excessive activation of the HPA axis, thereby increasing the levels of CRH, ACTH, CORT, and GC in the patients with depression and affecting the secretion in vivo [85, 86]. This evidence concerns the gene BCL2A1 and depressive disorder.